Investing

Bausch Health : BHC

BHC

Stock Data

$6.25

$0.34 (5.75%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - SPECIALTY & GENERIC

Bausch Health Companies Inc., headquartered in Laval, Canada, is a global player in the healthcare sector, focusing on specialty pharmaceuticals and medical devices. With a broad portfolio, the company targets key areas such as gastroenterology, neurology, dermatology, eye health, and more. It operates through distinct segments including Salix for gastroenterology products, International for a mix of devices and pharmaceuticals, Solta Medical for aesthetic devices, Diversified for a variety of therapeutic areas, and Bausch + Lomb for vision care and surgical products. Originally known as Valeant Pharmaceuticals, it rebranded in 2018 to better reflect its mission and scope.

Latest Activity

BHCBausch Health Companies Inc.

Q2 2026

Jul 29, 4:11pm ET

EPS

$1.26

est $1.01+25.1%

Revenue

$2.85B

est $2.66B+7.3%

Bausch Health smashed Q2 expectations with adjusted EPS of $1.26, blowing past consensus by 25%, as its blockbuster Xifaxan drug rocketed 26% higher to fuel a 21% surge in the Salix segment. The healthcare conglomerate hiked full-year guidance and nearly doubled operating cash flow while paring back its towering debt load, though it flagged 2027 risks from CMS-negotiated pricing on Xifaxan and lingering tariff uncertainty.

Loading…

ShareRead more

All Bausch Health Articles

6 Articles

Trey Thoelcke | Jan 31, 2026 at 8:15 AM EST

Insiders Are Still Scooping Up Under Armour and WR Berkley Shares

Insiders continue to scoop up Under Armour and W.R. Berkley shares, and a public offering of International Tower Hill Mines shares…

Joey Frenette | Dec 29, 2025 at 1:34 PM EST

2 Strong Mid-Cap Growth Stocks Dan Loeb Bought in Q3

Dan Loeb of Third Point is a brilliant investor worth watching closely whenever the 13F filings roll in. He’s a…

Trey Thoelcke | Aug 21, 2025 at 8:45 AM EDT

Insider Buys Top $333 Million as Icahn Exits Bausch Health Stake

One insider scooped up many shares as Carl Icahn exited his stake in a medical device maker. There were other…

Ian Cooper | Jun 24, 2025 at 9:10 AM EDT

Five Popular Stocks Insiders Have Been Aggressively Buying

One of the best ways to spot a potential opportunity is by tracking insiders. After all, who knows the company…

Trey Thoelcke | Jun 19, 2025 at 8:45 AM EDT

Insiders Make Huge Buys in Gold Miners and More

In the past week, a couple of gold-mining stocks attracted the attention of insider buyers. Billionaire hedge fund manager John…

Rich Duprey | Oct 3, 2024 at 7:53 PM EDT

Is John Paulson’s Best Investment Ever a Buy or Sell

The best investment billionaire John Paulson ever made was a bet against something. He famously predicted the collapse of the…